메뉴 건너뛰기




Volumn 21, Issue 3, 2014, Pages 383-394

Liposomal polychemotherapy improves adrenocortical carcinoma treatment in a preclinical rodent model

Author keywords

Adrenal cortex; Adrenocortical carcinoma; Chemotherapy; Lipoplatin; Liposomes; Preclinical animal model

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; MITOTANE; PACLITAXEL; 130-NM ALBUMIN-BOUND PACLITAXEL; ALBUMINOID; ANTINEOPLASTIC AGENT; MACROGOL DERIVATIVE;

EID: 84903519549     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-13-0439     Document Type: Article
Times cited : (22)

References (36)
  • 1
    • 33745777816 scopus 로고    scopus 로고
    • Clinical and biological features in the prognosis of adrenocortical cancer: Poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients
    • DOI 10.1210/jc.2005-2730
    • Abiven G, Coste J, Groussin L, Anract P, Tissier F, Legmann P, Dousset B, Bertagna X & Bertherat J 2006 Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. Journal of Clinical Endocrinology and Metabolism 91 2650-2655. (doi:10.1210/jc.2005-2730) (Pubitemid 44024632)
    • (2006) Journal of Clinical Endocrinology and Metabolism , vol.91 , Issue.7 , pp. 2650-2655
    • Abiven, G.1    Coste, J.2    Groussin, L.3    Anract, P.4    Tissier, F.5    Legmann, P.6    Dousset, B.7    Bertagna, X.8    Bertherat, J.9
  • 4
    • 4444333522 scopus 로고    scopus 로고
    • Low toxicity and anticancer activity of a novel liposomal cisplatin (lipoplatin) in mouse xenografts
    • Boulikas T 2004 Low toxicity and anticancer activity of a novel liposomal cisplatin (lipoplatin) in mouse xenografts. Oncology Reports 12 3-12.
    • (2004) Oncology Reports , vol.12 , pp. 3-12
    • Boulikas, T.1
  • 5
    • 0030990935 scopus 로고    scopus 로고
    • Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-Related Kaposi's sarcoma
    • Coukell AJ & Spencer CM 1997 Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma. Drugs 53 520-538. (doi:10.2165/00003495-199753030-00011) (Pubitemid 27117367)
    • (1997) Drugs , vol.53 , Issue.3 , pp. 520-538
    • Coukell, A.J.1    Spencer, C.M.2
  • 11
    • 0031881541 scopus 로고    scopus 로고
    • Paclitaxel is an effective antiproliferative agent on the human NCI-H295 adrenocortical carcinoma cell line
    • DOI 10.1159/000007104
    • Fallo F, Pilon C, Barzon L, Pistorello M, Pagotto U, Altavilla G, BoscaroM& Sonino N 1998 Paclitaxel is an effective antiproliferative agent on the human NCI-H295 adrenocortical carcinoma cell line. Chemotherapy 44 129-134. (doi:10.1159/000007104) (Pubitemid 28105426)
    • (1998) Chemotherapy , vol.44 , Issue.2 , pp. 129-134
    • Fallo, F.1    Pilon, C.2    Barzon, L.3    Pistorello, M.4    Pagotto, U.5    Altavilla, G.6    Boscaro, M.7    Sonino, N.8
  • 13
    • 0036875493 scopus 로고    scopus 로고
    • Liposomal drug carrier systems in cancer chemotherapy: Current status and future prospects
    • DOI 10.1080/1061186021000043061
    • Gabizon AA 2002 Liposomal drug carrier systems in cancer chemotherapy: current status and future prospects. Journal of Drug Targeting 10 535-538. (doi:10.1080/1061186021000043061) (Pubitemid 36124351)
    • (2002) Journal of Drug Targeting , vol.10 , Issue.7 , pp. 535-538
    • Gabizon, A.A.1
  • 14
    • 0037681850 scopus 로고    scopus 로고
    • Pharmacokinetics of pegylated liposomal doxorubicin: Review of animal and human studies
    • doi:10.2165/00003088-200342050-00002
    • Gabizon A, Shmeeda H & Barenholz Y 2003 Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies. Clinical Pharmacokinetics 42 419-436. (doi:10.2165/00003088-200342050-00002)
    • (2003) Clinical Pharmacokinetics , vol.42 , pp. 419-436
    • Gabizon, A.1    Shmeeda, H.2    Barenholz, Y.3
  • 15
    • 84856279574 scopus 로고    scopus 로고
    • Pharmacological basis of pegylated liposomal doxorubicin: Impact on cancer therapy
    • doi:10.1016/j.ejps.2011.09.006
    • Gabizon A, Shmeeda H & Grenader T 2011 Pharmacological basis of pegylated liposomal doxorubicin: impact on cancer therapy. European Journal of Pharmaceutical Sciences 45 388-398. (doi:10.1016/j.ejps.2011.09.006)
    • (2011) European Journal of Pharmaceutical Sciences , vol.45 , pp. 388-398
    • Gabizon, A.1    Shmeeda, H.2    Grenader, T.3
  • 16
    • 33745458519 scopus 로고    scopus 로고
    • Albumin-bound paclitaxel: A next-generation taxane
    • DOI 10.1517/14656566.7.8.1041
    • Gradishar WJ 2006 Albumin-bound paclitaxel: a next-generation taxane. Expert Opinion on Pharmacotherapy 7 1041-1053. (doi:10.1517/14656566.7.8.1041) (Pubitemid 43949942)
    • (2006) Expert Opinion on Pharmacotherapy , vol.7 , Issue.8 , pp. 1041-1053
    • Gradishar, W.J.1
  • 17
    • 76149110071 scopus 로고    scopus 로고
    • Anti insulin-like growth factor i receptor immunoliposomes: A single formulation combining two anticancer treatments with enhanced therapeutic efficiency
    • doi:10.1210/jc.2009-1980
    • Hantel C, Lewrick F, Schneider S, Zwermann O, Perren A, Reincke M, Suss R & Beuschlein F 2010 Anti insulin-like growth factor I receptor immunoliposomes: a single formulation combining two anticancer treatments with enhanced therapeutic efficiency. Journal of Clinical Endocrinology and Metabolism 95 943-952. (doi:10.1210/jc.2009-1980)
    • (2010) Journal of Clinical Endocrinology and Metabolism , vol.95 , pp. 943-952
    • Hantel, C.1    Lewrick, F.2    Schneider, S.3    Zwermann, O.4    Perren, A.5    Reincke, M.6    Suss, R.7    Beuschlein, F.8
  • 18
    • 84862063030 scopus 로고    scopus 로고
    • Liposomal doxorubicin-based treatment in a preclinical model of adrenocortical carcinoma
    • doi:10.1530/JOE-11-0427
    • Hantel C, Lewrick F, Reincke M, Suss R & Beuschlein F 2012 Liposomal doxorubicin-based treatment in a preclinical model of adrenocortical carcinoma. Journal of Endocrinology 213 155-161. (doi:10.1530/JOE-11-0427)
    • (2012) Journal of Endocrinology , vol.213 , pp. 155-161
    • Hantel, C.1    Lewrick, F.2    Reincke, M.3    Suss, R.4    Beuschlein, F.5
  • 19
    • 0036907725 scopus 로고    scopus 로고
    • Liposomally targeted cytotoxic drugs for the treatment of cancer
    • doi:10.1211/0022357002243
    • Harrington KJ, Syrigos KN & Vile RG 2002 Liposomally targeted cytotoxic drugs for the treatment of cancer. Journal of Pharmaceutics & Pharmacology 54 1573-1600. (doi:10.1211/0022357002243)
    • (2002) Journal of Pharmaceutics & Pharmacology , vol.54 , pp. 1573-1600
    • Harrington, K.J.1    Syrigos, K.N.2    Vile, R.G.3
  • 20
    • 61649093243 scopus 로고    scopus 로고
    • Tumor targeting using liposomal antineoplastic drugs
    • Huwyler J, Drewe J & Krahenbuhl S 2008 Tumor targeting using liposomal antineoplastic drugs. International Journal of Nanomedicine 3 21-29. (doi:10.2147/IJN.S1253) (Pubitemid 351517073)
    • (2008) International Journal of Nanomedicine , vol.3 , Issue.1 , pp. 21-29
    • Huwyler, J.1    Drewe, J.2    Krahenbuhl, S.3
  • 21
    • 34548482374 scopus 로고    scopus 로고
    • Stealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potential
    • doi:10.2217/17435889.1.3.297
    • Immordino ML, Dosio F & Cattel L 2006 Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. International Journal of Nanomedicine 1 297-315. (doi:10.2217/17435889.1.3.297)
    • (2006) International Journal of Nanomedicine , vol.1 , pp. 297-315
    • Immordino, M.L.1    Dosio, F.2    Cattel, L.3
  • 23
    • 34249810952 scopus 로고    scopus 로고
    • Adrenocortical cancer: Pathophysiology and clinical management
    • DOI 10.1677/erc.1.01130
    • Libe R, Fratticci A & Bertherat J 2007 Adrenocortical cancer: pathophysiology and clinical management. Endocrine-Related Cancer 14 13-28. (doi:10.1677/erc.1.01130) (Pubitemid 47521719)
    • (2007) Endocrine-Related Cancer , vol.14 , Issue.1 , pp. 13-28
    • Libe, R.1    Fratticci, A.2    Bertherat, J.3
  • 25
    • 0029090720 scopus 로고
    • Sequencedependent antitumor activity of paclitaxel (taxol) and cisplatin in vivo
    • doi:10.1002/ijc.2910620518
    • Milross CG, Peters LJ, Hunter NR, Mason KA & Milas L 1995 Sequencedependent antitumor activity of paclitaxel (taxol) and cisplatin in vivo. International Journal of Cancer 62 599-604. (doi:10.1002/ijc.2910620518)
    • (1995) International Journal of Cancer , vol.62 , pp. 599-604
    • Milross, C.G.1    Peters, L.J.2    Hunter, N.R.3    Mason, K.A.4    Milas, L.5
  • 26
    • 77950461582 scopus 로고    scopus 로고
    • Phase II study of liposomal cisplatin (lipoplatin) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer
    • doi:10.1016/j.lungcan.2009.06.017
    • Mylonakis N, Athanasiou A, Ziras N, Angel J, Rapti A, Lampaki S, Politis N, Karanikas C & Kosmas C 2009 Phase II study of liposomal cisplatin (lipoplatin) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer. Lung Cancer 68 240-247. (doi:10.1016/j.lungcan.2009.06.017)
    • (2009) Lung Cancer , vol.68 , pp. 240-247
    • Mylonakis, N.1    Athanasiou, A.2    Ziras, N.3    Angel, J.4    Rapti, A.5    Lampaki, S.6    Politis, N.7    Karanikas, C.8    Kosmas, C.9
  • 27
    • 36549050900 scopus 로고    scopus 로고
    • Single-agent treatment with pegylated liposomal doxorubicin for metastatic breast cancer
    • DOI 10.1097/CAD.0b013e3282f14a00, PII 0000181320080100000001
    • O'Brien ME 2008 Single-agent treatment with pegylated liposomal doxorubicin for metastatic breast cancer. Anti-Cancer Drugs 19 1-7. (doi:10.1097/CAD.0b013e3282f14a00) (Pubitemid 350190962)
    • (2008) Anti-Cancer Drugs , vol.19 , Issue.1 , pp. 1-7
    • O'Brien, M.E.R.1
  • 29
    • 0346343244 scopus 로고    scopus 로고
    • Current status of liposomal anthracycline therapy in metastatic breast cancer
    • doi:10.3816/CBC.2003.s.019
    • Rivera E 2003 Current status of liposomal anthracycline therapy in metastatic breast cancer. Clinical Breast Cancer 4 (Suppl 2) S76-S83. (doi:10.3816/CBC.2003.s.019)
    • (2003) Clinical Breast Cancer , vol.4 , Issue.SUPPL. 2
    • Rivera, E.1
  • 30
    • 0033745993 scopus 로고    scopus 로고
    • Etoposide encapsulated in positively charged liposomes: Pharmacokinetic studies in mice and formulation stability studies
    • doi:10.1006/phrs.2000.0714
    • Sengupta S, Tyagi P, Velpandian T, Gupta YK & Gupta SK 2000 Etoposide encapsulated in positively charged liposomes: pharmacokinetic studies in mice and formulation stability studies. Pharmacological Research 42 459-464. (doi:10.1006/phrs.2000.0714)
    • (2000) Pharmacological Research , vol.42 , pp. 459-464
    • Sengupta, S.1    Tyagi, P.2    Velpandian, T.3    Gupta, Y.K.4    Gupta, S.K.5
  • 31
    • 0036402578 scopus 로고    scopus 로고
    • Polyethylene glycol-liposomal doxorubicin: A review of its use in the management of solid and haematological malignancies and AIDS-related Kaposi's sarcoma
    • doi:10.2165/00003495-200262140-00012
    • SharpeM, Easthope SE, Keating GM& LambHM2002 Polyethylene glycol-liposomal doxorubicin: a review of its use in the management of solid and haematological malignancies and AIDS-related Kaposi's sarcoma. Drugs 62 2089-2126. (doi:10.2165/00003495-200262140-00012)
    • (2002) Drugs , vol.62 , pp. 2089-2126
    • Sharpe, M.1    Easthope, S.E.2    Keating, G.M.3    Lamb, H.M.4
  • 32
    • 70350307006 scopus 로고    scopus 로고
    • Pharmacokinetics and tissue distribution of liposomal etoposide in rats
    • doi:10.3109/10717540903223418
    • Sistla A, Smith DJ, Kobrinsky NL & Kumar K 2009 Pharmacokinetics and tissue distribution of liposomal etoposide in rats. Drug Delivery 16 423-429. (doi:10.3109/10717540903223418)
    • (2009) Drug Delivery , vol.16 , pp. 423-429
    • Sistla, A.1    Smith, D.J.2    Kobrinsky, N.L.3    Kumar, K.4
  • 33
    • 33745002266 scopus 로고    scopus 로고
    • Liposomal cisplatin combined with gemcitabine in pretreated advanced pancreatic cancerpatients: Aphase I-II study
    • StathopoulosGP, Boulikas T, Vougiouka M, Rigatos SK&Stathopoulos JG 2006 Liposomal cisplatin combined with gemcitabine in pretreated advanced pancreatic cancerpatients: aphase I-II study. OncologyReports 151201-1204.
    • (2006) OncologyReports , pp. 151201-151204
    • Stathopoulos, G.P.1    Boulikas, T.2    Vougiouka, M.3    Rigatos, S.K.4    Stathopoulos, J.G.5
  • 35
    • 51649088789 scopus 로고    scopus 로고
    • Paclitaxel encapsulated in cationic liposomes increases tumor microvessel leakiness and improves therapeutic efficacy in combination with Cisplatin
    • doi:10.1158/1078-0432.CCR-07-4738
    • Strieth S, Eichhorn ME, Werner A, Sauer B, Teifel M, Michaelis U, Berghaus A & Dellian M 2008 Paclitaxel encapsulated in cationic liposomes increases tumor microvessel leakiness and improves therapeutic efficacy in combination with Cisplatin. Clinical Cancer Research 14 4603-4611. (doi:10.1158/1078-0432.CCR-07-4738)
    • (2008) Clinical Cancer Research , vol.14 , pp. 4603-4611
    • Strieth, S.1    Eichhorn, M.E.2    Werner, A.3    Sauer, B.4    Teifel, M.5    Michaelis, U.6    Berghaus, A.7    Dellian, M.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.